Indication
Hyper-low-density Lipoprotein (LDL) Cholesterolemia
2 clinical trials
2 products
Clinical trial
A Multicenter, Open-label, Uncontrolled, Long-term Trial to Assess the Safety and Efficacy of ETC-1002 in Patients With Hyper-LDL CholesterolemiaStatus: Active (not recruiting), Estimated PCD: 2024-10-31
Product
ETC-1002Clinical trial
A Placebo-controlled, Randomized, Multicenter, Double-blind, Parallel-group Trial to Confirm the Superiority of ETC-1002 in Patients With Hyper-LDL CholesterolemiaStatus: Completed, Estimated PCD: 2024-02-20
Product
Placebo